<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005776</url>
  </required_header>
  <id_info>
    <org_study_id>NICHD-NRN-0014</org_study_id>
    <secondary_id>U01HD019897</secondary_id>
    <secondary_id>U10HD021364</secondary_id>
    <secondary_id>U10HD021373</secondary_id>
    <secondary_id>U10HD021385</secondary_id>
    <secondary_id>U10HD021397</secondary_id>
    <secondary_id>U10HD021415</secondary_id>
    <secondary_id>U10HD027851</secondary_id>
    <secondary_id>U10HD027853</secondary_id>
    <secondary_id>U10HD027856</secondary_id>
    <secondary_id>U10HD027871</secondary_id>
    <secondary_id>U10HD027880</secondary_id>
    <secondary_id>U10HD027881</secondary_id>
    <secondary_id>U10HD027904</secondary_id>
    <secondary_id>U10HD034167</secondary_id>
    <secondary_id>U10HD034216</secondary_id>
    <secondary_id>M01RR000070</secondary_id>
    <secondary_id>M01RR000750</secondary_id>
    <secondary_id>M01RR000997</secondary_id>
    <secondary_id>M01RR001032</secondary_id>
    <secondary_id>M01RR006022</secondary_id>
    <secondary_id>M01RR008084</secondary_id>
    <nct_id>NCT00005776</nct_id>
  </id_info>
  <brief_title>Inhaled Nitric Oxide Study for Respiratory Failure in Newborns</brief_title>
  <acronym>NINOS</acronym>
  <official_title>The Randomized Inhaled Nitric Oxide Study (NINOS) in Full-Term and Nearly Full-Term Infants With Hypoxic Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NICHD Neonatal Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Research Council of Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>NICHD Neonatal Research Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory failure in term newborns is associated with increased rates of death and
      long-term neurodevelopmental problems. This large international multicenter trial randomized
      newborns who had failed to respond to intensive care, including high levels of ventilator
      support, to receive either inhaled nitric oxide (iNO) or 100 percent oxygen to test whether
      iNO would decrease their risk of dying or requiring temporary lung bypass. Infants were
      followed during their initial hospitalization; their outcome was assessed at 18 to 24 mos of
      age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Respiratory failure in term newborns is associated with significant morbidity and mortality,
      despite maximal conventional therapy. Neonates with pulmonary hypertension have been treated
      with iNO, a selective pulmonary vasodilator. This multicenter, double-masked
      placebo-controlled randomized trial tested whether iNO would reduce the risk of death and/or
      the initiation of extracorporeal membrane oxygenation (ECMO) in a prospectively defined
      cohort of term or near-term neonates with hypoxic respiratory failure unresponsive to
      conventional therapy. The sample size was based on a reduction of the primary event (death or
      ECMO) from 50 percent to 30 percent; 90 percent power; and a two-tailed Type I error of 0.05.

      Infants were evaluated at baseline for pulmonary, cardiac, bleeding status, and therapies
      received. Those who were greater than 34 wks gestation and 14 days old or less and required
      assisted ventilation with an OI (mean airway pressure x FiO2 divided by the PaO2 x 100)
      greater than 25 were eligible. They were randomly assigned to receive iNO at 20 ppm or 100
      percent oxygen as a control. Infants whose PaO2 increased by less than 20 mm Hg after 30
      minutes were studied at 80ppm iNO or control gas.; MetHg and NO2 concentrations were
      monitored regularly. Management, including surfactant administration, included prospectively
      defined criteria for study gas response, escalation, reinitiation, and weaning. The maximum
      total time on study gas was 336 hrs (after 240 hrs, the INO concentration was required to be
      no more than 5 ppm). Patients were followed to death, discharge, or 120 days and evaluated at
      18-24 mos by a masked certified examiner.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Results showed statistically significant benefit in the experimental group
  </why_stopped>
  <start_date>October 1995</start_date>
  <completion_date type="Actual">May 1998</completion_date>
  <primary_completion_date type="Actual">May 1996</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death or initiation of ECMO</measure>
    <time_frame>Before hospital discharge or 120 days of life</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PaO2 levels, oxygenation index, and alveolar-arterial oxygen gradient</measure>
    <time_frame>30 minutes after drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopmental outcome</measure>
    <time_frame>18-22 Months Corrected Age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of assisted ventilation, air leaks, or chronic lung disease</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfers for ECMO</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Meeting ECMO criteria</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">235</enrollment>
  <condition>Infant, Newborn</condition>
  <condition>Hypertension, Pulmonary</condition>
  <condition>Persistent Fetal Circulation Syndrome</condition>
  <condition>Pneumonia, Aspiration</condition>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>Inhaled Nitric Oxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inhaled Nitric Oxide (iNO)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100% oxygen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled nitric oxide</intervention_name>
    <description>Inhaled Nitric oxide at a concentration of 20 ppm</description>
    <arm_group_label>Inhaled Nitric Oxide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>100% Oxygen</description>
    <arm_group_label>Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Greater than 34 wks gestational age

          -  One or more of the following diagnoses: primary pulmonary hypertension of the newborn,
             respiratory distress syndrome, perinatal aspiration syndrome, pneumonia/sepsis,
             suspected pulmonary hypoplasia

          -  Oxygenation Index (OI) greater than 15 and less than 25 on 2 arterial blood gases at
             least 15 min apart

          -  Indwelling arterial line

          -  Echocardiography before randomization

          -  Parental consent

        Exclusion Criteria:

          -  Congenital diaphragmatic hernia

          -  Known congenital heart disease

          -  Decision not to provide full therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard A. Ehrenkranz, MD</last_name>
    <role>Study Director</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David K. Stevenson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raymond Bain, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>George Washington University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James A. Lemons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seetha Shankaran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wayne State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lu-Ann Papile, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward F. Donovan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Avroy A. Fanaroff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Western Reserve University, Rainbow Babies and Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William William Oh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University, Women &amp; Infants Hospital of Rhode Island</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sheldon B. Korones, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tennessee</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary Wearden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>N. Singhal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foothills Hospital, Calgary, Canada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil N. Finer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Alexandra Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A. Solimano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>British Columbia Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>C. Fajardo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Health Sciences Center, Winnipeg, Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>H. Kirpalani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>R. Walker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Eastern Ontario</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A. Johnston, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montreal Children's Hospital of the MUHC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>P. Blanchard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke, Sherbrooke, Quebec</affiliation>
  </overall_official>
  <overall_official>
    <last_name>K. Sankarhan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal University Hospital, Saskatoon, Saskatchewan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University, Rainbow Babies and Children's Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown University, Women &amp; Infants Hospital of Rhode Island</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Tennessee</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>British Columbia Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Sciences Center</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Children's Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Université de Sherbrooke,</name>
      <address>
        <city>Sherbrooke,</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://neonatal.rti.org</url>
    <description>NICHD Neonatal Research Network</description>
  </link>
  <link>
    <url>http://www.nichd.nih.gov/cochrane/FINER/FINER.HTM</url>
    <description>Cochrane meta-analysis: &quot;Nitric oxide for respiratory failure infants born at or near term.&quot;</description>
  </link>
  <link>
    <url>http://www.nichd.nih.gov/cochrane/Barrington5/BARRINGTON5.HTM</url>
    <description>Cochrane meta-analysis: &quot;Inhaled nitric oxide in preterm newborn infants with respiratory failure.&quot;</description>
  </link>
  <results_reference>
    <citation>Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997 Feb 27;336(9):597-604. Erratum in: N Engl J Med 1997 Aug 7;337(6):434.</citation>
    <PMID>9036320</PMID>
  </results_reference>
  <results_reference>
    <citation>Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Pediatrics. 1997 Jun;99(6):838-45.</citation>
    <PMID>9190553</PMID>
  </results_reference>
  <results_reference>
    <citation>Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr. 2000 May;136(5):611-7.</citation>
    <PMID>10802492</PMID>
  </results_reference>
  <results_reference>
    <citation>Sokol GM, Fineberg NS, Wright LL, Ehrenkranz RA. Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide. Pediatr Pulmonol. 2001 Jul;32(1):14-9.</citation>
    <PMID>11416871</PMID>
  </results_reference>
  <results_reference>
    <citation>Sokol GM, Ehrenkranz RA. Inhaled nitric oxide therapy in neonatal hypoxic respiratory failure: insights beyond primary outcomes. Semin Perinatol. 2003 Aug;27(4):311-9. Review.</citation>
    <PMID>14510322</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2000</study_first_submitted>
  <study_first_submitted_qc>June 1, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2000</study_first_posted>
  <last_update_submitted>September 22, 2017</last_update_submitted>
  <last_update_submitted_qc>September 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <name_title>Richard A. Ehrenkranz, NRN Lead Study Investigator</name_title>
    <organization>Yale University School of Medicine</organization>
  </responsible_party>
  <keyword>NICHD Neonatal Research Network</keyword>
  <keyword>Hypertension, pulmonary</keyword>
  <keyword>Hypoxic respiratory failure</keyword>
  <keyword>Meconium aspiration</keyword>
  <keyword>Methemoglobinemia</keyword>
  <keyword>Nitric oxide</keyword>
  <keyword>Oxygen inhalation therapy</keyword>
  <keyword>Persistent Fetal Circulation Syndrome</keyword>
  <keyword>Pneumonia, aspiration</keyword>
  <keyword>Respiratory distress syndrome</keyword>
  <keyword>Respiratory insufficiency</keyword>
  <keyword>Severe respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Persistent Fetal Circulation Syndrome</mesh_term>
    <mesh_term>Pneumonia, Aspiration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

